Combined use of metformin and atorvastatin attenuates atherosclerosis in rabbits fed a high-cholesterol diet (Q33708461)

28 July 2017

Combined use of metformin and atorvastatin attenuates atherosclerosis in rabbits fed a high-cholesterol diet (English)

1 reference

28 July 2017

1 reference

1 reference

Fei Luo

1

1 reference

28 July 2017

Yuan Guo

2

1 reference

28 July 2017

Gui-Yun Ruan

3

1 reference

28 July 2017

Jun-Ke Long

4

1 reference

28 July 2017

Xi-Long Zheng

5

1 reference

28 July 2017

Qin Xia

6

1 reference

28 July 2017

Shui-Ping Zhao

7

1 reference

28 July 2017

Dao-Quan Peng

8

1 reference

28 July 2017

Zhen-Fei Fang

9

1 reference

28 July 2017

Xiang-Ping Li

10

1 reference

28 July 2017

language of work or name

English

0 references

publication date

19 May 2017

1 reference

28 July 2017

1 reference

28 July 2017

7

1 reference

28 July 2017

2169

1 reference

28 July 2017

1

1 reference

Creative Commons Attribution 4.0 International

28 July 2017

start time

19 May 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

describes a project that uses

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC5438352/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

exact match

https://scigraph.springernature.com/pub.10.1038/s41598-017-02080-w

0 references

cites work

Metformin promotes cholesterol efflux in macrophages by up-regulating FGF21 expression: a novel anti-atherosclerotic mechanism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Modulation of microRNA Expression in Subjects with Metabolic Syndrome and Decrease of Cholesterol Efflux from Macrophages via microRNA-33-Mediated Attenuation of ATP-Binding Cassette Transporter A1 Expression by Statins

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

MicroRNAs and Endothelial (Dys) Function

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Metformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Akt inhibition promotes ABCA1-mediated cholesterol efflux to ApoA-I through suppressing mTORC1.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Application of microRNAs in diagnosis and treatment of cardiovascular disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

A selective microRNA-based strategy inhibits restenosis while preserving endothelial function

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Urotensin II promotes atherosclerosis in cholesterol-fed rabbits

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Antagonism of betulinic acid on LPS-mediated inhibition of ABCA1 and cholesterol efflux through inhibiting nuclear factor-kappaB signaling pathway and miR-33 expression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Adenosine monophosphate-activated protein kinase induces cholesterol efflux from macrophage-derived foam cells and alleviates atherosclerosis in apolipoprotein E-deficient mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Inflammation impairs reverse cholesterol transport in vivo.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

High-density lipoprotein particle size and concentration and coronary risk

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Synthetic LXR ligand inhibits the development of atherosclerosis in mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Atheroma progression in hyporesponders to statin therapy.

21 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-02080-W

Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-02080-W

The effect of metformin on monocyte secretory function in simvastatin-treated patients with impaired fasting glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-02080-W

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-02080-W

Metformin inhibits nuclear factor kappaB activation and decreases serum high-sensitivity C-reactive protein level in experimental atherogenesis of rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-02080-W

NF-κB suppresses the expression of ATP-binding cassette transporter A1/G1 by regulating SREBP-2 and miR-33a in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-02080-W

HMG-CoA reductase inhibitors, simvastatin and atorvastatin, downregulate ABCG1-mediated cholesterol efflux in human macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-02080-W

High-density lipoprotein subfractions in relation with the severity of coronary artery disease: A Gensini score assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-02080-W

Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-02080-W

Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-02080-W

Risk of new-onset diabetes mellitus versus reduction in cardiovascular events with statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-02080-W

Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-02080-W

Small HDL particles containing two apoA-I molecules are precursors in vivo to medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5438352

Atorvastatin delays the glucose clearance rate in hypercholesterolemic rabbits

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28526884

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/S41598-017-02080-W

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference